Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics First Quarter 2025 Financial and Operating Results Conference Call.
Neuronetics Inc. (STIM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Balyasny Asset Management Dmitry Balyasny | 1,417,051 | $5,214,748 | -5% | 0.01% |
| 2. | Ikarian Capital Neil Shahrestani | 1,100,000 | $4,048,000 | 0.5% | |
| 3. | Masters Capital Management Mike Masters | 1,000,000 | $3,680,000 | -34% | 0.18% |
| 4. | Manatuck Hill Partners Mark Broach | 920,000 | $3,385,600 | 1.56% | |
| 5. | Millennium Management Israel Englander | 657,725 | $2,420,428 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.75 | 100,000 | $75,000.00 | 453,098 | 2024-09-12 | Filing | |
| $0.80 | 25,000 | $20,000.00 | 289,818 | 2024-09-05 | Filing | |
| $0.85 | 12,224 | $10,390.40 | 264,818 | 2024-08-29 | Filing | |
| $0.85 | 12,776 | $10,859.60 | 252,594 | 2024-08-28 | Filing | |
| $1.00 | 25,000 | $25,000.00 | 239,818 | 2024-08-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.16 | 6,540 | $27,206.40 | 410,053 | 2025-05-13 | Filing | |
| $4.27 | 193,460 | $826,074.20 | 416,593 | 2025-05-12 | Filing | |
| $4.48 | 1,867 | $8,364.16 | 610,053 | 2025-03-04 | Filing | |
| $4.48 | 377 | $1,688.96 | 526,805 | 2025-03-04 | Filing | |
| $4.70 | 24,440 | $114,868.00 | 1,232,988 | 2025-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,306,070 | $8,486,337 | 0% | |
| 2. | 761,911 | $2,803,832 | 0% | |
| 3. | 630,393 | $2,319,846 | 0% | |
| 4. | 475,267 | $1,748,983 | 0% | |
| 5. | 415,870 | $1,530,404 | 0% |
News See All
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
Neuronetics, Inc. (NASDAQ:STIM) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics Fourth Quarter 2024 Financial and Operating Results Conference Call.
10 Hot Penny Stocks to Buy Now
On January 2, Royce Investment Partners published their analysis regarding the performance of the small caps during the fourth quarter of 2024.
Neuronetics, Inc. (NASDAQ:STIM) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Neuronetics Third Quarter 2024 Financial and Operating Results Conference Call.
Neuronetics, Inc. (NASDAQ:STIM) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics second quarter 2024 financial and operating results conference call. [Operator Instructions].
Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript
Neuronetics, Inc. beats earnings expectations. Reported EPS is $-0.26713, expectations were $-0.33.
Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Neuronetics Report Fourth Quarter 2023 Financial and Operating Results.
Neuronetics, Inc. (NASDAQ:STIM) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Neuronetics Third Quarter 2023 Conference Call.
Neuronetics, Inc. (NASDAQ:STIM) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by, welcome to the Neuronetics Second Quarter 2023 Financial and Operating Results Conference Call. At this time al participants’ are in a listen-only mode.